Nina Kuprasertkul

Nina Kuprasertkul

Auto-generated profile, based on publicly available information

Nina Kuprasertkul

Duke University, Durham, North Carolina

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2023 in Science Advances
Verified
Journal Article
Open access
LILuke T. Izzo
Luke T. Izzo
STSophie Trefely
Sophie Trefely
CDChristina Demetriadou
Christina Demetriadou
JDJack M. Drummond
Jack M. Drummond
TMTakuya Mizukami
Takuya Mizukami
KWKathryn E. Wellen
Kathryn E. Wellen
The metabolite acetyl-CoA is necessary for both lipid synthesis in the cytosol and histone acetylation in the nucleus. The two canonical precursors to acetyl-CoA in the nuclear-cytoplasmic compartment are citrate and acetate, which are processed to acetyl-CoA by ATP-citrate lyase (ACLY) and acyl-CoA synthetase short-chain 2 (ACSS2), respectively. It is unclear whether other substantial routes to nuclear-cytosolic acetyl-CoA exist. To investigate this, we generated cancer cell lines lacking both ACLY and ACSS2 [double knockout (DKO) cells]. Using stable isotope tracing, we show that both glucose and fatty acids contribute to acetyl-CoA pools and histone acetylation in DKO cells and that acetylcarnitine shuttling can transfer two-carbon units from mitochondria to cytosol. Further, in the absence of ACLY, glucose can feed fatty acid synthesis in a carnitine responsive and carnitine acetyltransferase (CrAT)-dependent manner. The data define acetylcarnitine as an ACLY- and ACSS2-independent precursor to nuclear-cytosolic acetyl-CoA that can support acetylation, fatty acid synthesis, and cell growth.

13 August 2014 in Physics and Chemistry of Liquids
Verified
Journal Article
Closed access
MBMichela Brumfield
Michela Brumfield
AWAkash Wadawadigi
Akash Wadawadigi
NKNapasorn Kuprasertkul
Napasorn Kuprasertkul
SMSumedha Mehta
Sumedha Mehta
WAWilliam E. Acree
William E. Acree
MAMichael H. Abraham
Michael H. Abraham

1 September 2023 in Science Advances
Verified
Journal Article
Open access
ALAlexandra Maldonado López
Alexandra Maldonado López
EKEun Kyung Ko
Eun Kyung Ko
SHSijia Huang
Sijia Huang
GPGina Pacella
Gina Pacella
NKNina Kuprasertkul
Nina Kuprasertkul
BCBrian Capell
Brian Capell
N6 -methyladenosine (m 6 A) is the most abundant modification on messenger RNAs (mRNAs) and is catalyzed by methyltransferase-like protein 3 (Mettl3). To understand the role of m 6 A in a self-renewing somatic tissue, we deleted Mettl3 in epidermal progenitors in vivo. Mice lacking Mettl3 demonstrate marked features of dysfunctional development and self-renewal, including a loss of hair follicle morphogenesis and impaired cell adhesion and polarity associated with oral ulcerations. We show that Mettl3 promotes the m 6 A-mediated degradation of mRNAs encoding critical histone modifying enzymes. Depletion of Mettl3 results in the loss of m 6 A on these mRNAs and increases their expression and associated modifications, resulting in widespread gene expression abnormalities that mirror the gross phenotypic abnormalities. Collectively, these results have identified an additional layer of gene regulation within epithelial tissues, revealing an essential role for m 6 A in the regulation of chromatin modifiers, and underscoring a critical role for Mettl3-catalyzed m 6 A in proper epithelial development and self-renewal.

27 March 2014 in Physics and Chemistry of Liquids
Verified
Journal Article
Closed access
TSTimothy W. Stephens
Timothy W. Stephens
EHErin Hart
Erin Hart
NKNapasorn Kuprasertkul
Napasorn Kuprasertkul
SMSumedha Mehta
Sumedha Mehta
AWAkash Wadawadigi
Akash Wadawadigi
MAMichael H. Abraham
Michael H. Abraham
Gas-to-ionic liquid (IL) partition coefficients have been compiled from the published literature for solutes dissolved in anhydrous 1-butyl-3-methylimidazolium 4,5-dicyano-2-(trifluoromethyl)imidazolide, ([BMIm]+[TDI]–), and 3-methyl-N-butylpyridinium 4,5-dicyano-2-(trifluoromethyl)imidazolide, ([3-MBPy]+[TDI]–). The compiled partition coefficients were converted to water-to-IL partition coefficients using the corresponding gas-to-water partition coefficients. Both sets of partition coefficients were analysed using the ion-specific equation coefficient version of the Abraham solvation parameter model. Equation coefficients are determined for the first time for 4,5-dicyano-2-(trifluoromethyl)imidazolide. Mathematical correlations derived from the Abraham model describe the observed gas-to-IL and water-to-IL partition coefficient data to within a standard deviation of 0.07 and 0.11 log units, respectively.

31 May 2018 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
MDMichael Deel
Michael Deel
KSKatherine K. Slemmons
Katherine K. Slemmons
AHAshley R. Hinson
Ashley R. Hinson
KGKatia C. Genadry
Katia C. Genadry
BBBreanne A. Burgess
Breanne A. Burgess
CLCorinne Linardic
Corinne Linardic
Purpose: Alveolar rhabdomyosarcoma (aRMS) is a childhood soft tissue sarcoma driven by the signature PAX3-FOXO1 (P3F) fusion gene. Five-year survival for aRMS is <50%, with no improvement in over 4 decades. Although the transcriptional coactivator TAZ is oncogenic in carcinomas, the role of TAZ in sarcomas is poorly understood. The aim of this study was to investigate the role of TAZ in P3F-aRMS tumorigenesis. Experimental Design: After determining from publicly available datasets that TAZ is upregulated in human aRMS transcriptomes, we evaluated whether TAZ is also upregulated in our myoblast-based model of P3F-initiated tumorigenesis, and performed IHC staining of 63 human aRMS samples from tissue microarrays. Using constitutive and inducible RNAi, we examined the impact of TAZ loss of function on aRMS oncogenic phenotypes in vitro and tumorigenesis in vivo. Finally, we performed pharmacologic studies in aRMS cell lines using porphyrin compounds, which interfere with TAZ-TEAD transcriptional activity. Results: TAZ is upregulated in our P3F-initiated aRMS model, and aRMS cells and tumors have high nuclear TAZ expression. In vitro, TAZ suppression inhibits aRMS cell proliferation, induces apoptosis, supports myogenic differentiation, and reduces aRMS cell stemness. TAZ-deficient aRMS cells are enriched in G2–M phase of the cell cycle. In vivo, TAZ suppression attenuates aRMS xenograft tumor growth. Preclinical studies show decreased aRMS xenograft tumor growth with porphyrin compounds alone and in combination with vincristine. Conclusions: TAZ is oncogenic in aRMS sarcomagenesis. While P3F is currently not therapeutically tractable, targeting TAZ could be a promising novel approach in aRMS. Clin Cancer Res; 24(11); 2616–30. ©2018 AACR.

1 October 2018 in Cancer Research
Verified
Journal Article
Closed access
PDF file
KOKristianne M. Oristian
Kristianne M. Oristian
LCLisa E.S. Crose
Lisa E.S. Crose
NKNina Kuprasertkul
Nina Kuprasertkul
RBRex C. Bentley
Rex C. Bentley
YLYi-Tzu Lin
Yi-Tzu Lin
CLCorinne Linardic
Corinne Linardic
A hallmark of fusion-positive alveolar rhabdomyosarcoma (aRMS) is the presence of a chromosomal translocation encoding the PAX3–FOXO1 fusion oncogene. Primary cell-based modeling experiments have shown that PAX3–FOXO1 is necessary, but not sufficient for aRMS tumorigenesis, indicating additional molecular alterations are required to initiate and sustain tumor growth. Previously, we showed that PAX3–FOXO1-positive aRMS is promoted by dysregulated Hippo pathway signaling, as demonstrated by increased YAP1 expression and decreased MST activity. We hypothesized that ablating MST/Hippo signaling in a genetically engineered mouse model (GEMM) of aRMS would accelerate tumorigenesis. To this end, MST1/2-floxed (Stk3F/F;Stk4F/F) mice were crossed with a previously established aRMS GEMM driven by conditional expression of Pax3:Foxo1 from the endogenous Pax3 locus and conditional loss of Cdkn2a in Myf6 (myogenic factor 6)-expressing cells. Compared with Pax3PF/PF;Cdkn2aF/F;Myf6ICN/+ controls, Stk3F/F;Stk4F/F;Pax3PF/PF;Cdkn2aF/F;Myf6ICN/+ animals displayed accelerated tumorigenesis (P < 0.0001) and increased tumor penetrance (88% vs. 27%). GEMM tumors were histologically consistent with aRMS. GEMM tumor-derived cell lines showed increased proliferation and invasion and decreased senescence and myogenic differentiation. These data suggest that loss of MST/Hippo signaling acts with Pax3:Foxo1 expression and Cdkn2a loss to promote tumorigenesis. The rapid onset and increased penetrance of tumorigenesis in this model provide a powerful tool for interrogating aRMS biology and screening novel therapeutics. Significance: A novel mouse model sheds light on the critical role of Hippo/MST downregulation in PAX3-FOXO1–positive rhabdomyosarcoma tumorigenesis. Cancer Res; 78(19); 5513–20. ©2018 AACR.